MARC Record from marc_columbia

LEADER: 10445cam a22003494a 4500
001 5518216
005 20221121180653.0
008 050503s2006 paua 000 0 eng
015 $aGBA575492$2bnb
016 7 $a013287787$2Uk
020 $a0781749956 (hbk.)
035 $a(OCoLC)ocm61477951
035 $a(NNC)5518216
035 $a5518216
040 $aUKM$cUKM$dNNC-M$dOrLoB-B
082 04 $a616.85306$222
090 $aRC372$b.T68 2006
245 00 $aTreatment of epilepsy :$bprinciples and practice /$ceditor-in-chief, Elaine Wyllie ; associate editors, Ajay Gupta, Deepak K. Lachhwani.
250 $a4th ed.
260 $aPhiladelphia, Pa. ;$aLondon :$bLippincott Williams & Wilkins,$c2006.
300 $axxi, 1247 pages :$billustrations (some color) ;$c29 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
505 00 $tForeword /$rDaniel H. Lowenstein -- $g1.$tAtlas of pathologic substrates of epilepsy /$rRichard A. Prayson and Ajay Gupta -- $g2.$tHuman nervous system development and malformations /$rHarvey B. Sarnat and Laura Flores-Sarnat -- $g3.$tMalformations of cortical development and epilepsy /$rWilliam B. Dobyns and Ruben Kuzniecky -- $g4.$tHippocampal anatomy and hippocampal sclerosis /$rImad Najm, Henri Duvernoy and Stephan Schuele -- $g5.$tBasic cellular neurophysiology /$rStephen W. Jones -- $g6.$tMechanisms of epileptogenesis and experimental models of seizures /$rImad Najm, Gabriel Moddel and Damir Janigro -- $g7.$tGenetic aspects of epilepsy and genetics of idiopathic generalized epilepsy /$rAjay Gupta and Ingrid E. Scheffer -- $g8.$tEpidemiologic aspects of epilepsy /$rAnne T. Berg -- $g9.$tThe natural history of seizures /$rW. Allen Hauser -- $g10.$tNeurophysiologic basis of the electroencephalogram /$rErwin-Josef Speckmann, Christian E. Elger and Ulrich Altrup -- $g11.$tLocalization and field determination in electroencephalography and magnetoencephalography /$rRichard C. Burgess, Masaki Iwasaki and Dileep Nair -- $g12.$tApplication of electroencephalography in the diagnosis of epilepsy /$rDavid R. Chabolla and Gregory D. Cascino -- $g13.$tElectroencephalographic atlas of epileptiform abnormalities /$rSoheyl Noachtar and Elaine Wyllie -- $g14.$tClassification of seizures /$rChristoph Kellinghaus, Hans O. Luders and Elaine Wyllie -- $gApp.$tProposal for revised clinical and electrographic classification of epileptic seizures : Commission on Classification and Terminology of the International League Against Epilepsy (1981) -- $g15.$tEpileptic auras /$rNorman K. So -- $g16.$tFocal seizures with impaired consciousness /$rPrakash Kotagal and Tobias Loddenkemper -- $g17.$tFocal motor seizures, epilepsia partialis continua, and supplementary sensorimotor seizures /$rAndreas V. Alexopoulos and Dudley S. Dinner -- $g18.$tGeneralized tonic-clonic seizures /$rBruce J. Fisch and Piotr W. Olejniczak -- $g19.$tAbsence seizures /$rSelim R. Benbadis and Samuel F. Berkovic -- $g20.$tAtypical absence, myoclonic, tonic, and atonic seizures /$rWilliam O. Tatum IV and Kevin Farrell -- $g21.$tEpileptic spasms /$rW. Donald Shields and Susan Koh -- $g22.$tClassification of the epilepsies /$rTobias Loddenkemper, Hans O. Luders, Imad M. Najm and Elaine Wyllie -- $gApp.$tProposal for revised classification of epilepsies and epileptic syndromes : Commission on Classification and Terminology of the International League Against Epilepsy (1989) -- $g23.$tSymptomatic focal epilepsies /$rNancy Foldvary-Schaefer -- $g24.$tIdiopathic and benign partial epilepsies of childhood /$rElaine C. Wirrell, Carol S. Camfield and Peter R. Camfield -- $g25.$tIdiopathic generalized epilepsy syndromes of childhood and adolescence /$rTobias Loddenkemper, Selim R. Benbadis, Jose M. Serratosa and Samuel F. Berkovic -- $g26.$tThe myoclonic epilepsies /$rRenzo Guerrini, Paolo Bonanni, Carla Marini and Lucio Parmeggiani -- $g27.$tEncephalopathic generalized epilepsy and Lennox-Gastaut syndrome /$rKevin Farrell and William O. Tatum IV -- $g28.$tRasmussen's encephalitis (chronic focal encephalitis) /$rFrancois Dubeau -- $g29.$tContinuous spike wave of slow sleep and Landau-Kleffner syndrome /$rBrian Neville and J. Helen Cross -- $g30.$tEpilepsy with reflex seizures /$rBenjamin G. Zifkin and Frederick Andermann -- $g31.$tLess common epilepsy syndromes and epilepsy associated with chromosomal abnormalities /$rSophia Varadkar and J. Helen Cross -- $g32.$tNeonatal seizures /$rRobert R. Clancy and Eli M. Mizrahi -- $g33.$tFebrile seizures /$rMichael Duchowny -- $g34.$tPosttraumatic epilepsy /$rJayanthi Mani and Elizabeth Barry -- $g35.$tEpilepsy in the setting of cerebrovascular disease /$rBernd Pohlmann-Eden, Martin Del Campo, Neil R. Friedman and Deepak K. Lachhwani -- $g36.$tEpilepsy in the setting of neurocutaneous syndromes /$rPrakash Kotagal and Deepak K. Lachhwani -- $g37.$tEpilepsy in the setting of inherited metabolic and mitochondrial disorders /$rLinda D. Leary, Douglas R. Nordli, Jr. and Darryl C. De Vivo -- $g38.$tSeizures associated with nonneurologic medical conditions /$rStephan Eisenschenk and Robin L. Gilmore -- $g39.$tEpilepsy in patients with multiple handicaps /$rJohn M. Pellock -- $g40.$tEpilepsy in the elderly /$rIlo E. Leppik and Angela K. Birnbaum -- $g41.$tStatus epilepticus /$rJames J. Riviello, Jr. -- $g42.$tPsychogenic nonepileptic seizures /$rSelim R. Benbadis -- $g43.$tOther nonepileptic paroxysmal disorders /$rJohn M. Pellock -- $g44.$tAntiepileptic drug development and experimental models /$rJacqueline A. French -- $g45.$tPharmacokinetics and pharamacodynamics of antiepileptic drugs /$rBlaise F. D. Bourgeois -- $gApp.$tSelected drug interactions between antiepileptic drugs and other types of medications /$rKay C. Kyllonen and Ajay Gupta -- $g46.$tPharmacokinetics of antiepileptic drugs in infants and children /$rGail D. Anderson and Jong M. Rho -- $g47.$tInitiation and discontinuation of antiepileptic drugs /$rVarda Gross Tsur, Christine O'Dell and Shlomo Shinnar -- $g48.$tHormones, catamenial epilepsy, and reproductive and bone health in epilepsy /$rMartha J. Morrell -- $g49.$tTreatment of epilepsy during pregnancy /$rNancy Foldvary-Schaefer -- $g50.$tTreatment of epilepsy in the setting of renal and liver disease /$rJane G. Boggs, Elizabeth Waterhouse and Robert J. DeLorenzo -- $g51.$tMonitoring for adverse effects of antiepileptic drugs /$rL. James Willmore, Andrew Pickens IV and John M. Pellock -- $g52.$tPharmacogenetics of antiepileptic medications /$rTracy A. Glauser and Diego A. Morita -- $g53.$tCarbamazepine and oxcarbazepine /$rCarlos A. M. Guerreiro and Marilisa M. Guerreiro -- $g54.$tValproate /$rBlaise F. D. Bourgeois -- $g55.$tPhenytoin and fosphenytoin /$rDiego A. Morita and Tracy A. Glauser -- $g56.$tPhenobarbital and primidone /$rBlaise F. D. Bourgeois -- $g57.$tEthosuximide /$rTracy A. Glauser and Diego A. Morita -- $g58.$tBenzodiazepines /$rL. John Greenfield, Jr., Howard C. Rosenberg and Richard W. Homan -- $g59.$tGabapentin and pregabalin /$rMichael J. McLean and Barry E. Gidal -- $g60.$tLamotrigine /$rFrank G. Gilliam and Barry E. Gidal -- $g61.$tTopiramate /$rMichael D. Privitera -- $g62.$tZonisamide /$rTimothy E. Welty -- $g63.$tLevetiracetam /$rJoseph I. Sirven and Joseph F. Drazkowski -- $g64.$tTiagabine /$rSteven C. Schachter -- $g65.$tFelbamate /$rR. Edward Faught -- $g66.$tVigabatrin /$rElinor Ben-Menachem -- $g67.$tAdrenocorticotropin and steroids /$rMelinda A. Nolan and O. Carter Snead III -- $g68.$tNewer antiepileptic drugs /$rNorman Delanty and Jacqueline A. French -- $g69.$tLess commonly used entiepileptic drugs /$rBasim M. Uthman and Ahmad Beydoun -- $g70.$tThe ketogenic diet /$rDouglas R. Nordli, Jr. and Darryl C. De Vivo -- $g71.$tVagus nerve stimulation therapy /$rJames W. Wheless -- $g72.$tIssues of medical intractability for surgical candidacy /$rPatrick Kwan and Martin J. Brodie -- $g73.$tRecognition of potential surgical candidates and video-electroencephalographic evaluation /$rGregory D. Cascino -- $g74.$tMagnetic resonance imaging techniques in the evaluation for epilepsy surgery /$rSusanne Knake and P. Ellen Grant -- $g75.$tThe intracarotid amobarbital procedure /$rMax R. Trenerry and David W. Loring -- $g76.$tMetabolic and functional neuroimaging /$rWilliam D. Gaillard -- $g77.$tIntracranial electroencephalography and localization studies /$rSelim R. Benbadis, Elaine Wyllie and William E. Bingaman -- $g78.$tHippocampal sclerosis and dual pathology /$rEvan J. Fertig and Susan S. Spencer -- $g79.$tResection for uncontrolled epilepsy in the setting of focal lesions on MRI : tumor, vascular malformation, trauma, and infarction /$rDennis D. Spencer and Alexandre C. Carpentier -- $g80.$tEpilepsy surgery in focal malformations of cortical development /$rJorge A. Gonzalez-Martinez, Imad M. Najm, William E. Bingaman and Paul M. Ruggieri -- $g81.$tHemispherectomy : medications, technical approaches, and results /$rJose Luis Montes, Jean-Pierre Farmer, Frederick Andermann and Chantal Poulin --
505 80 $g82.$tEpilepsy surgery in the absence of a lesion on magnetic resonance imaging /$rElson L. So -- $g83.$tEpilepsy surgery in infants and children /$rAjay Gupta, Elaine Wyllie and William E. Bingaman -- $g84.$tCorpus callosotomy and multiple subpial transections /$rMichael C. Smith, Richard Byrne and Andres M. Kanner -- $g85.$tNewer operative and stereotactic techniques and their application to hypothalamic hamartoma /$rA. Simon Harvey and Jeremy L. Freeman -- $g86.$tOutcome and complications of epilepsy surgery /$rDeepak K. Lachhwani and Elaine Wyllie -- $g87.$tCognitive effects of epilepsy and antiepileptic medications /$rKimford J. Meador -- $g88.$tPsychiatric comorbidity of epilepsy /$rSteven C. Schachter -- $g89.$tDriving and social issues in epilepsy /$rJoseph F. Drazkowski and Joseph I. Sirven -- $gApp.$tIndications for antiepileptic drugs sanctioned by the United States Food and Drug Administration /$rKay C. Kyllonen.
650 0 $aEpilepsy$xTreatment.
650 12 $aEpilepsy$xtherapy.$0https://id.nlm.nih.gov/mesh/D004827Q000628
650 22 $aEpilepsy$xdiagnosis.$0https://id.nlm.nih.gov/mesh/D004827Q000175
700 1 $aWyllie, Elaine.$0http://id.loc.gov/authorities/names/n92803913
700 1 $aGupta, Ajay,$d1965-$0http://id.loc.gov/authorities/names/n2005183286
700 1 $aLachhwani, Deepak K.$0http://id.loc.gov/authorities/names/n2011186373
852 00 $boff,hsl$hRC372$i.T68 2006 Q